CN112717060A - Formula for treating lung cancer - Google Patents

Formula for treating lung cancer Download PDF

Info

Publication number
CN112717060A
CN112717060A CN202110266106.6A CN202110266106A CN112717060A CN 112717060 A CN112717060 A CN 112717060A CN 202110266106 A CN202110266106 A CN 202110266106A CN 112717060 A CN112717060 A CN 112717060A
Authority
CN
China
Prior art keywords
parts
lung cancer
treating lung
formula
radix rehmanniae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110266106.6A
Other languages
Chinese (zh)
Inventor
朱一中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110266106.6A priority Critical patent/CN112717060A/en
Publication of CN112717060A publication Critical patent/CN112717060A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to a formula for treating lung cancer. The formula for treating lung cancer comprises the following components in parts by weight: 20-35 parts of adenophora stricta; 15-20 parts of radix rehmanniae; 1-5 parts of Sichuan feet; 20-40 parts of houttuynia cordata; 15-20 parts of red peony root; 10-15 parts of whole worm; 15-20 parts of seaweed; 5-15 parts of safflower; 15-20 parts of bulbus fritilariae; 20-30 parts of lucid ganoderma; 20-40 parts of oyster; 10-15 parts of stir-fried armor. The formula for treating lung cancer provided by the invention can be used for treating lung cancer, improving clinical symptoms, enhancing disease resistance and relieving the post-radiotherapy and chemotherapy symptoms.

Description

Formula for treating lung cancer
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a formula for treating lung cancer.
Background
The majority of primary lung cancers originate from bronchi, also called bronchogenic lung cancer, which is one of the common lung cancers in the respiratory system, is mostly seen in men over 40 years old, and belongs to the range of cough, chest distress and hemoptysis in traditional Chinese medicine. However, the medical science considers that the occurrence of lung cancer is related to smoking, so that the cigarette contains carcinogens, the pathological forms of lung cancer cells can be classified into squamous epithelial carcinoma, adenocarcinoma and undifferentiated carcinoma clinically, and the lung cancer cells can be classified into central type (located near the lung portal and occurring in main bronchus and lung lobe bronchus) and peripheral type (located in the peripheral part of the lung and occurring in small bronchus) according to the occurrence parts of the lung cancer cells, and the lung cancer cells are usually metastasized through lymphatic vessels or blood circulation.
The traditional Chinese medicine considers that the disease is caused by the deficiency of vital qi and the invasion of pathogenic toxin to the lung: the spleen, liver and kidney are closely related; spleen deficiency causing cancer, phlegm congealing and generating fire, ascending the lung, consuming qi and damaging fluid, liver depression for a long time, qi and blood stasis, blood stasis and pathogenic toxin accumulating in the lung and blocking the airway to cause diseases, and kidney deficiency without receiving qi.
Disclosure of Invention
Aiming at the defects in the prior art, the formula for treating lung cancer provided by the invention solves the technical problems.
In order to achieve the purpose, the invention provides the following technical scheme:
a formula for treating lung cancer comprises the following components in parts by weight: 20-35 parts of adenophora stricta; 15-20 parts of radix rehmanniae; 1-5 parts of Sichuan feet; 20-40 parts of houttuynia cordata; 15-20 parts of red peony root; 10-15 parts of whole worm; 15-20 parts of seaweed; 5-15 parts of safflower; 15-20 parts of bulbus fritilariae; 20-30 parts of lucid ganoderma; 20-40 parts of oyster; 10-15 parts of stir-fried armor.
A formula for treating lung cancer comprises the following components in parts by weight: 30 parts of adenophora stricta; 18 parts of radix rehmanniae; 3 parts of Sichuan feet; 30 parts of houttuynia cordata; 18 parts of red peony root; 13 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 18 parts of bulbus fritilariae; 25 parts of lucid ganoderma; 30 parts of oyster; 12 parts of stir-fried armor.
A formula for treating lung cancer comprises the following components in parts by weight: 25 parts of adenophora stricta; 18 parts of radix rehmanniae; 4 parts of Sichuan feet; 25 parts of houttuynia cordata; 15 parts of red peony root; 15 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 17 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 12 parts of stir-fried armor.
A formula for treating lung cancer comprises the following components in parts by weight: 30 parts of adenophora stricta; 20 parts of radix rehmanniae; 4 parts of Sichuan feet; 20 parts of houttuynia cordata; 17 parts of red paeony root; 13 parts of whole worm; 19 parts of seaweed; 12 parts of safflower; 16 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 14 parts of stir-fried armor.
A formula for treating lung cancer is prepared by the following steps: adding radix Adenophorae, radix rehmanniae, radix Aconiti, herba Houttuyniae, radix Paeoniae Rubra, Scorpio, Sargassum, Carthami flos, Bulbus Fritillariae Cirrhosae, Ganoderma, Concha Ostreae and parched squama Manis into water, adding appropriate amount of water, decocting with slow fire for 2-3 hr, and decocting with water.
Another preparation method of the formula for treating lung cancer comprises the following steps: the raw materials are processed into powder according to the weight ratio of the raw materials, and then the powder is prepared into a granular preparation according to a certain dosage.
The invention has the beneficial effects that: according to the formula for treating lung cancer provided by the invention, the lung cancer is treated by traditional Chinese medicine, the clinical symptoms and the disease resistance can be improved, and the post-radiotherapy and chemotherapy treatment can be relieved.
Part of the traditional Chinese medicine components in the invention have certain anticancer effect so as to improve the curative effect.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A formula for treating lung cancer comprises the following components in parts by weight: 20-35 parts of adenophora stricta; 15-20 parts of radix rehmanniae; 1-5 parts of Sichuan feet; 20-40 parts of houttuynia cordata; 15-20 parts of red peony root; 10-15 parts of whole worm; 15-20 parts of seaweed; 5-15 parts of safflower; 15-20 parts of bulbus fritilariae; 20-30 parts of lucid ganoderma; 20-40 parts of oyster; 10-15 parts of stir-fried armor.
Example 1:
a formula for treating lung cancer comprises the following components in parts by weight: 30 parts of adenophora stricta; 18 parts of radix rehmanniae; 3 parts of Sichuan feet; 30 parts of houttuynia cordata; 18 parts of red peony root; 13 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 18 parts of bulbus fritilariae; 25 parts of lucid ganoderma; 30 parts of oyster; 12 parts of stir-fried armor.
A formula for treating lung cancer is prepared by the following steps: adding radix Adenophorae, radix rehmanniae, rhizoma Ligustici Chuanxiong, herba Houttuyniae, radix Paeoniae Rubra, Scorpio, Sargassum, Carthami flos, Bulbus Fritillariae Cirrhosae, Ganoderma, Concha Ostreae and parched squama Manis into water, adding appropriate amount of water, decocting with slow fire for 2.5 hr, and decocting with water.
Example 2:
a formula for treating lung cancer comprises the following components in parts by weight: 25 parts of adenophora stricta; 18 parts of radix rehmanniae; 4 parts of Sichuan feet; 25 parts of houttuynia cordata; 15 parts of red peony root; 15 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 17 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 12 parts of stir-fried armor.
A formula for treating lung cancer is prepared by the following steps: adding radix Adenophorae, radix rehmanniae, radix Aconiti, herba Houttuyniae, radix Paeoniae Rubra, Scorpio, Sargassum, Carthami flos, Bulbus Fritillariae Cirrhosae, Ganoderma, Concha Ostreae and parched squama Manis into water, adding appropriate amount of water, decocting with slow fire for 3 hr, and decocting with water.
Example 3:
a formula for treating lung cancer comprises the following components in parts by weight: 30 parts of adenophora stricta; 20 parts of radix rehmanniae; 4 parts of Sichuan feet; 20 parts of houttuynia cordata; 17 parts of red paeony root; 13 parts of whole worm; 19 parts of seaweed; 12 parts of safflower; 16 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 14 parts of stir-fried armor.
A formula for treating lung cancer is prepared by the following steps: adding radix Adenophorae, radix rehmanniae, radix Aconiti, herba Houttuyniae, radix Paeoniae Rubra, Scorpio, Sargassum, Carthami flos, Bulbus Fritillariae Cirrhosae, Ganoderma, Concha Ostreae and parched squama Manis into water, adding appropriate amount of water, decocting with slow fire for 2 hr, and decocting with water.
Another preparation method of the formula for treating lung cancer comprises the following steps: the raw materials are processed into powder according to the weight ratio of the raw materials, and then the powder is prepared into a granular preparation according to a certain dosage.
Typical cases are as follows:
case 1: in summer, male is 50 years old, and the hospital confirms lung cancer through CT examination and chemotherapy for 3 times due to dry cough and emaciation, and the patient is nausea, vomiting, hypodynamia and poor in spirit and stops chemotherapy. After 2 courses of administration of the traditional Chinese medicine prepared in example 1, symptoms are partially relieved, and after 7 courses of administration, the lesions disappear for half and live up to now.
Case 2: du Zhi, female, 46 years old, was diagnosed with left lung cancer by CT because of cough, 12 months of phlegm with blood, chest distress, and short breath. After the traditional Chinese medicine prepared in the embodiment 2 is taken for 4 courses of treatment, the symptoms are relieved, the spirit is obviously improved, the symptoms of lung cancer focus are partially relieved after the traditional Chinese medicine is continuously taken for 4 courses of treatment, and the survival time is 2 years and half.
Case 3: blood stasis and toxin are coagulated after radiotherapy and chemotherapy, and the coagulated blood and toxin are in the lung and blocked in the airway of a patient to cause coarse breath, dyspnea, cyanosis and chest distress; cough is not comfortable when lung descends first, phlegm with blood when heat injures lung Luo, so it is indicated for qi-moving and blood-activating, phlegm-resolving and hardness-softening, and lung stasis-resolving decoction. In the invention, the liquorice, the houttuynia cordata and the earthworm are beneficial to lung and phlegm reduction, the safflower, the scorpion and the Sichuan foot are used for activating blood and dissolving stasis, and the selfheal, the fried shell and the seaweed are used for softening and resolving hard mass; after 5 courses of administration, the symptoms are obviously relieved.
Each treatment course in the present invention is 7 days.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (6)

1. The formula for treating lung cancer is characterized by comprising the following components in parts by weight: 20-35 parts of adenophora stricta; 15-20 parts of radix rehmanniae; 1-5 parts of Sichuan feet; 20-40 parts of houttuynia cordata; 15-20 parts of red peony root; 10-15 parts of whole worm; 15-20 parts of seaweed; 5-15 parts of safflower; 15-20 parts of bulbus fritilariae; 20-30 parts of lucid ganoderma; 20-40 parts of oyster; 10-15 parts of stir-fried armor.
2. The formula for treating lung cancer according to claim 1, which is characterized by comprising the following components in parts by weight: 30 parts of adenophora stricta; 18 parts of radix rehmanniae; 3 parts of Sichuan feet; 30 parts of houttuynia cordata; 18 parts of red peony root; 13 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 18 parts of bulbus fritilariae; 25 parts of lucid ganoderma; 30 parts of oyster; 12 parts of stir-fried armor.
3. The formula for treating lung cancer according to claim 1, which is characterized by comprising the following components in parts by weight: 25 parts of adenophora stricta; 18 parts of radix rehmanniae; 4 parts of Sichuan feet; 25 parts of houttuynia cordata; 15 parts of red peony root; 15 parts of whole worm; 18 parts of seaweed; 10 parts of safflower; 17 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 12 parts of stir-fried armor.
4. The formula for treating lung cancer according to claim 1, which is characterized by comprising the following components in parts by weight: 30 parts of adenophora stricta; 20 parts of radix rehmanniae; 4 parts of Sichuan feet; 20 parts of houttuynia cordata; 17 parts of red paeony root; 13 parts of whole worm; 19 parts of seaweed; 12 parts of safflower; 16 parts of bulbus fritilariae; 22 parts of lucid ganoderma; 23 parts of oyster; 14 parts of stir-fried armor.
5. The formulation for treating lung cancer according to claim 1, which is prepared by the following steps: adding radix Adenophorae, radix rehmanniae, radix Aconiti, herba Houttuyniae, radix Paeoniae Rubra, Scorpio, Sargassum, Carthami flos, Bulbus Fritillariae Cirrhosae, Ganoderma, Concha Ostreae and parched squama Manis into water, adding appropriate amount of water, decocting with slow fire for 2-3 hr, and decocting with water.
6. The formulation for treating lung cancer according to claim 1, which is prepared by the following steps: the raw materials are processed into powder according to the weight ratio of the raw materials, and then the powder is prepared into a granular preparation according to a certain dosage.
CN202110266106.6A 2021-03-11 2021-03-11 Formula for treating lung cancer Pending CN112717060A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110266106.6A CN112717060A (en) 2021-03-11 2021-03-11 Formula for treating lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110266106.6A CN112717060A (en) 2021-03-11 2021-03-11 Formula for treating lung cancer

Publications (1)

Publication Number Publication Date
CN112717060A true CN112717060A (en) 2021-04-30

Family

ID=75595846

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110266106.6A Pending CN112717060A (en) 2021-03-11 2021-03-11 Formula for treating lung cancer

Country Status (1)

Country Link
CN (1) CN112717060A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1698738A (en) * 2005-04-06 2005-11-23 齐学文 Chinese medicine for treating cancer
CN102920965A (en) * 2012-11-26 2013-02-13 陈骑龙 Traditional Chinese medicine water-bindered pill for treating advanced lung cancer
CN106390026A (en) * 2016-10-28 2017-02-15 李爱伏 Traditional Chinese medicine treatment composition aiming at middle and late period primary lung cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1698738A (en) * 2005-04-06 2005-11-23 齐学文 Chinese medicine for treating cancer
CN102920965A (en) * 2012-11-26 2013-02-13 陈骑龙 Traditional Chinese medicine water-bindered pill for treating advanced lung cancer
CN106390026A (en) * 2016-10-28 2017-02-15 李爱伏 Traditional Chinese medicine treatment composition aiming at middle and late period primary lung cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吴红宇等: "中医中药结合化疗治疗肺癌的疗效观察", 《中国肿瘤临床与康复》 *
徐宏喜等: "《抗肿瘤中药现代研究与临床应用》", 30 September 2018, 上海科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN103768398B (en) Traditional Chinese medicine composition for treating advanced lung tumors
CN102579967A (en) Traditional Chinese medicinal composition for treating lung cancer
WO2012139314A1 (en) Chinese herbal medicinal composition for treating cancer
CN104547525A (en) Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof
CN106620391B (en) A kind of drug and preparation method thereof for treating advanced Non-small cell lung
CN103041291B (en) Traditional Chinese medicine for treating lung cancer
CN102764371B (en) Traditional Chinese medicine compound prescription for relieving radiotherapy side reactions and preparation method and application thereof
CN103211954B (en) Chinese medicinal preparation for treating radiation pneumonitis
CN112717060A (en) Formula for treating lung cancer
CN112294940A (en) Traditional Chinese medicine composition for treating tumors and application thereof
WO2018090850A1 (en) Chinese medicine composition for boosting vital energy and managing cachexia, and preparation method and chinese medicine formulation thereof
CN103816413B (en) A kind of Chinese medicine preparation for the treatment of postoperative pneumonia
CN103656469A (en) Compound cantharides traditional Chinese medicine composition and use of preparation thereof in preparation of medicine for treating radiation-induced pulmonary injury
CN108272989A (en) Treat the Chinese medicine composition of lung cancer
CN106963932B (en) Traditional Chinese medicine composition for invigorating spleen and recovering stomach and preparation method and application thereof
CN104324280A (en) Traditional Chinese medicine composition for treating nasopharynx cancer and preparation method of traditional Chinese medicine composition
CN104352990A (en) Pharmaceutical composition for treating thyroid cancer
CN104127572A (en) Preparation method for traditional Chinese medicine composition for treating lung cancer
CN102872361B (en) Traditional Chinese medicine composite for treating radiation pneumonitis
CN103920080A (en) Traditional Chinese medicine for treating acute and chronic bronchitis
CN104116846A (en) Preparation method of antitumor traditional Chinese medicine composition
CN102920977B (en) Traditional Chinese medicine composition for treating liver cancer
CN105902865A (en) Traditional Chinese medicine preparation for treating tumors and preparation method thereof
CN104800693B (en) A kind of Chinese medicine composition for treating lung cancer
CN107115495A (en) Effect a radical cure the Chinese herbal medicine formula of cancer and leukaemia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination